Skip to content

To study the effect of Kanchanara and Madhunashini two ayurvedic drug in treatment of the advanced oral cancer.

Efficacy of Kanchanara and Madhunashini in Palliative treatment of the advanced oral cancer: A pilot study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033332
Enrollment
45
Registered
2021-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx Health Condition 2: C00-D49- Neoplasms

Interventions

Intervention1: KANCHANARA GUGGULU & MADHUNASHINI CHOORNA: KANCHANARA GUGGULU 2 â?? 0 â?? 2 MADHUNASHINI CHOORNA ½ - 0 â?? ½ tsp with Tandulodaka (Rice water)for 1 year The patients will be given ora

Sponsors

Yenepoya Deemed to be University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Oral squamous cell carcinoma (OSCC) patients with progressive disease who have completed definitive treatment - OSCC patients coming with a local recurrence after a disease-free interval of more than 6 months, who are not amenable for any standard treatment - Adult patients above the age of 18 years - Patients with good physical performance status - Patients who are able to give an informed consent

Exclusion criteria

Exclusion criteria: - Patients who can have conventional anti-cancer therapy - Patients who are not willing to participate in the trial - Patients who have grade IV Trismus - Patients with poor performance status - Patients who are younger than 18 years - Patients who are unable to give an informed consent due to poor mental status

Design outcomes

Primary

MeasureTime frame
Increase in the Quality of life of oral cancer patient.Timepoint: Clinical assessment will be done at the end of 3rd, 6th, 9th and 12th month. Radiological assessment will be done at the end of one year. Quality of life with respect to the mentioned parameters will be addressed during the above intervals.

Secondary

MeasureTime frame
Increase in the Quality of life of oral cancer patient.Timepoint: Quality of life with respect to the mentioned parameters will be addressed during the above intervals.

Countries

India

Contacts

Public ContactDr Keshava prasada

Yenepoya (Deemed to be University)

rohanthomas@gmail.com9035082737

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026